Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
When patients lose significant weight on incretin-based therapiesoften 10-15% or more of initial body weight in clinical trials such as the STEP program (semaglutide) and SURMOUNT trials (tirzepatide)the reduction in subcutaneous fat decreases the body's natural insulation layer, making environmental temperatures feel colder than before
Cardiology 2010;116:178-82
The liquid form allows for easy dosing and pleasant intake
Tracks Medication Doses and Injection Sites These journals often include body diagrams to guide you in rotating injection sites safely
Eating quickly is flagged separately as its own trigger, because it distends the stomach faster than the slowed emptying can handle
In type 2 diabetes, it often outperforms older therapies on both blood sugar and weight, which is why it is quickly becoming a backbone drug in highrisk metabolic patients. Better glycemic control cuts the risk of microvascular complications (eye disease, kidney damage, nerve damage) and macrovascular events (heart attack, stroke) over time. Fewer amputations, fewer cases of kidney failure, and fewer disabling strokes are core drivers of lost lifeyears and compressed healthspan that tirzepatide helps push back against. 3
US$ 23.02
US$ 28.23
US$ 23.23
US$ 20.87
US$ 25.37
US$ 29.75
US$ 27.37
US$ 22.32
US$ 29.62
US$ 25.86
